Intelligence Platform
Patents
Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12377155
Bicyclic peptide ligands specific for PSMA
granted patentUS 12318454
Bicyclic peptide ligands specific for MT1-MMP
granted patentUS 11912794
Modulation of structured polypeptide specificity
granted patentUS 11814447
Peptide ligands for binding to EphA2
granted patentUS 11753444
Modulation of structured polypeptide specificity
granted patentUS 11746126
Bicyclic peptide ligands with detectable moieties and uses thereof
granted patentUS 11672868
Bicyclic peptide ligands specific for MT1-MMP
granted patentUS 11623012
Bicyclic peptide ligands specific for EphA2
granted patentUS 11433137
Compounds for treating cancer
granted patentUS 11414488
Methods for treating cancer
granted patentUS 11103591
Bicyclic peptide ligands specific for MT1-MMP
granted patentUS 10994019
Bicyclic peptide-toxin conjugates specific for MT1-MMP
granted patentUS 10899798
Bicyclic peptide ligands with detectable moieties and uses thereof
granted patentUS 10894808
Polypeptide ligands specific for plasma kallikrein
granted patentUS 10870679
Modulation of structured polypeptide specificity
granted patentUS 10800813
Modulation of structured polypeptide specificity
granted patentUS 10792368
Bicyclic peptide ligands specific for MT1-MMP
granted patentUS 10624968
Compounds for treating cancer
granted patentUS 10532106
Bicyclic peptide ligands specific for MT1-MMP
granted patentUS 10441663
Methods for treating cancer
granted patentUS 10294274
Polypeptide ligands specific for plasma kallikrein
granted patentUS 10118947
Modulation of structured polypeptide specificity
granted patentUS 9994617
Modulation of structured polypeptide specificity
granted